🇺🇸 FDA
Patent

US 12077760

DNA aptamers and use thereof for the treatment of cancer

granted A61KA61K31/337A61K33/243

Quick answer

US patent 12077760 (DNA aptamers and use thereof for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/337, A61K33/243, A61P, A61P35/00